The fleshy area on the back of the arm, between the shoulder and elbow
Improvement of at least one stage of fibrosis without worsening of MASH was achieved in 32,8% of the placebo group versus 59,1%, 53,3%, and 54,2% at the three tirzepatide levels
The research team sought to determine whether these variants also disrupt GLP-1
Specifically in colon cancer and prostate cancer, exendin-4 increased intracellular cAMP levels while inhibiting glycogen synthase kinase 3 and ERK-MAPK activation, leading to an increase in apoptosis [93]
COMMON SIDE EFFECTS As with any medication, some patients may experience side effects while adjusting to Semaglutide or Tirzepatide treatment